Text Size
2 studies found for:    weill | Open Studies | "Hepatitis C, Chronic"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Open-Label Study of GS-7977+ Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
Condition: Chronic Hepatitis C
Interventions: Drug: GS-7977 in combination with ribavirin;   Drug: GS-7977 400mg QD+ RBV BID+ PEG
2 Recruiting Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)
Condition: Hepatitis C Virus
Interventions: Drug: Asunaprevir (ASV);   Drug: Daclatasvir (DCV);   Drug: PBO matching ASV;   Drug: Placebo (PBO) matching DCV;   Drug: Pegylated-interferon alfa 2a (PegIFN);   Drug: Ribavirin (RBV)
To Top

† Indicates status has not been verified in more than two years